These genetic errors of heme metabolism, although rare, appear to be more common than previously thought, and recent treatment advances have improved the outlook for patients with the diagnoses, according to the American Gastroenterological Association.
Clebopride ranked first for efficacy, followed by domperidone, and no other drug was superior to placebo for improving symptoms of gastroparesis, according to a recent meta-analysis.
In a cohort study, U.K. residents with high genetic risk for inflammatory bowel disease who met four or five lifestyle measures developed Crohn's disease or ulcerative colitis at higher-than-average rates, but at about half the rate of those with both genetic risk and an unhealthy lifestyle.
This month's quiz asks readers to determine the most appropriate next step in treatment for a 30-year-old patient with progressively worsening epigastric pain that is more severe with eating and has not improved with proton-pump inhibitor (PPI) therapy.
The diagnostic approach to celiac disease in adults using serological and histologic data remains unchanged from the American College of Gastroenterology's (ACG) 2013 clinical guidelines.
While more than half of eligible patients with cirrhosis and concurrent nonvalvular atrial fibrillation did not receive anticoagulation between 2012 and 2019, use of direct oral anticoagulants (DOACs) increased substantially during that time, a recent study found.
A strategy that monitored Epstein-Barr virus (EBV) viral load after liver transplant in adults was associated with decreased incidence of post-transplant lymphoproliferative disease (PTLD), a retrospective Dutch study found.
Reports on ibuprofen-induced liver injury, emphysematous gastritis, and cholecystalgia resulting from gallbladder edema were published in the past month.